Xilio Therapeutics, Inc. (XLO)
Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
8. 88
-0.15
-1.6611%
$
59.37M Market Cap
- P/E Ratio
- Div Yield
55,700 Volume
-1.47 Eps
$ 9.03
Previous Close Want to track XLO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Xilio Therapeutics, Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| ADD Andrew D. Dickinson GILEAD SCIENCES Inc. | 650,389 | $8.73M | $5.85M | -$2.88M | -32.94% |
| SRB Steve R. Bailey Frazier Life Sciences Management LP | 422,505 | $3.55M | $3.8M | $249,277.95 | 7.02% |
